These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24738326)

  • 1. [A review: the role of antimicrobial peptide LL-37 in chronic sinusitis].
    Zong Y; Li J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):141-2. PubMed ID: 24738326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of LL-37 and IL-8 in chronic sinusitis with nasal polyps].
    Xie D; Guo Y; Wu D; Xie D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Apr; 24(8):337-40. PubMed ID: 20556966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory epithelium inflammation in a mouse model.
    Alt JA; Qin X; Pulsipher A; Orb Q; Orlandi RR; Zhang J; Schults A; Jia W; Presson AP; Prestwich GD; Oottamasathien S
    Int Forum Allergy Rhinol; 2015 Dec; 5(12):1141-50. PubMed ID: 26346056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LL-37 promotes neutrophil extracellular trap formation in chronic rhinosinusitis with nasal polyps.
    Cao Y; Chen F; Sun Y; Hong H; Wen Y; Lai Y; Xu Z; Luo X; Chen Y; Shi J; Li H
    Clin Exp Allergy; 2019 Jul; 49(7):990-999. PubMed ID: 31046155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis patients in a nasal explant model.
    Ooi EH; Wormald PJ; Carney AS; James CL; Tan LW
    Am J Rhinol; 2007; 21(3):367-72. PubMed ID: 17621825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
    Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
    Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease.
    Jiang YY; Xiao W; Zhu MX; Yang ZH; Pan XJ; Zhang Y; Sun CC; Xing Y
    Respir Med; 2012 Dec; 106(12):1680-9. PubMed ID: 22981321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
    Tjabringa GS; Rabe KF; Hiemstra PS
    Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
    Wang G; Mishra B; Epand RF; Epand RM
    Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinonasal epithelial cells synthesize active vitamin D, augmenting host innate immune function.
    Sultan B; Ramanathan M; Lee J; May L; Lane AP
    Int Forum Allergy Rhinol; 2013 Jan; 3(1):26-30. PubMed ID: 23038277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.
    Fabisiak A; Murawska N; Fichna J
    Pharmacol Rep; 2016 Aug; 68(4):802-8. PubMed ID: 27117377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease.
    Kahlenberg JM; Kaplan MJ
    J Immunol; 2013 Nov; 191(10):4895-901. PubMed ID: 24185823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?].
    Schauber J; Ruzicka T; Rupec RA
    Hautarzt; 2008 Jan; 59(1):72-4. PubMed ID: 18209993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites.
    Rico-Mata R; De Leon-Rodriguez LM; Avila EE
    Exp Parasitol; 2013 Mar; 133(3):300-6. PubMed ID: 23274811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique features of human cathelicidin LL-37.
    Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
    Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
    Fahy RJ; Wewers MD
    Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cathelicidin LL-37-derived peptide IG-19 confers protection in a murine model of collagen-induced arthritis.
    Chow LN; Choi KY; Piyadasa H; Bossert M; Uzonna J; Klonisch T; Mookherjee N
    Mol Immunol; 2014 Feb; 57(2):86-92. PubMed ID: 24091294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cathelicidins in the innate host defenses of mammals.
    Zanetti M
    Curr Issues Mol Biol; 2005 Jul; 7(2):179-96. PubMed ID: 16053249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis.
    Kienhöfer D; Hahn J; Schubert I; Reinwald C; Ipseiz N; Lang SC; Borràs ÈB; Amann K; Sjöwall C; Barron AE; Hueber AJ; Agerberth B; Schett G; Hoffmann MH
    PLoS One; 2014; 9(12):e115474. PubMed ID: 25535966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.